10.1002/chem.201705927
Chemistry - A European Journal
FULL PAPER
Aldehyde 15: To a solution of weinreb amide 14 (250 mg, 662 µmol) in
dry THF (5 ml) was added dropwise LiAlH4 (207 µL, 725 µmol, 3.5 M in
THF/toluene) at -78°C. After 30 min NaHSO4 solution (25 ml, 5 wt%) was
added and the mixture was allowed to warm to room temperature. The
mixture was diluted by addition of DCM (50 ml), the organic phase was
separated, washed with sat. NaHSO4 solution (2 x 50 ml, 5 wt%), dried
over MgSO4 and concentrated in vacuo. The desired product (183 mg, 575
µmol, 87%) was isolated as brown oil after purification by flash-
fragmentation cascade suggest means for potentially improved
designs of cleavable ligation auxiliaries. In ongoing work we
deliberately avoid α-substituents and rather focus on variations of
β-substituents, which on the one hand may enable faster ligation
reactions and on the other hand allow tuning of the speed of
radical formation and radical fragmentation. We expect that β-
substituted β-mercaptoethyl scaffolds will become a highly useful
tool for the rapid total synthesis of (posttranslationally modified)
proteins by native chemical ligation beyond cysteine and glycine.
chromatography on silica-gel using cyclohexane
→ cyclohexane/
ethylacetate/EDMA (2/1/0.01) as a mobile phase. 1H-NMR (500 MHz,
CDCl3): δ = 8.77-8.76 (t, J = 2.5 Hz, 1H), 7.38-7.35 (m, 3H), 7.24-7.16 (m,
12H), 3.02-3.01 (d, J = 2.5 Hz, 2H). 13C-NMR (126 MHz, CDCl3): δ = 196.7,
144.2, 129.7, 128.3, 127.3, 67.6, 42.6.
Experimental Section
Allyl chloride 18: To a suspension of 4-nitrophenylacetic acid 17 (10.0 g,
55.2 mmol) and paraformaldehyde (4.01 g, 132 mmol) in toluene (25 ml)
was added morpholine (4.8 ml, 4.75 g, 55. 6 mmol). The reaction mixture
was heated (90°C, 1 h→ 100°C, 4 h) and subsequently concentrated in
vacuo. The residue was dissolved in DCM (50 ml), the organic phase
washed with water (2 x 25 ml) and concentrated in vacuo. The desired
morpholine derivative (6.34 g, 25.6 mmol, 47%) was isolated as a yellow
solid after purification by flash-chromatography on silica-gel using
cyclohexane/ethylacetate (3/1) as a mobile phase. 1H-NMR (500 MHz,
CDCl3): δ = 8.18-8.16 (dd, J1 = 9.0 Hz, J2 = 0.5 Hz, 2H), 7.71-7.68 (m, , J1
= 9.0 Hz, J2 = 2.5 Hz, 2H) 5.64 (d, J = 1.0 Hz, 1H) , 5.41 (d, J = 1.0 Hz,
1H), 3.66-3.64 (t, J = 4.5 Hz, 4H), 3.35 (d, J = 0.5 Hz, 2H), 2.46-2.45 (t, J
= 4.5 Hz, 4H). 13C-NMR (126 MHz, CDCl3): δ = 146.7, 142.4, 127.3, 123.6,
119.3, 67.1, 63.5, 53.5. HRMS (ESI): m/z = 249.1235 (C19H24NO5S2
(M+H)+, calc.: 249.1239); C13H16N2O3: 248.28 g·mol−1.To a solution of the
morpholine derivative (2.85 g, 11.5 mmol) in toluene (5 ml) was added
dropwise isobutyl chloroformate (1.8 ml, 1.89 g, 13.8 mmol). After 18 h the
reaction mixture was concentrated in vacuo. The desired product (1.73 g,
8.77 mmol, 76%) was isolated as a yellow oil after purification by flash-
chromatography on silica-gel using cyclohexane/ethylacetate (3/1) as a
mobile phase. 1H-NMR (500 MHz, CDCl3): δ = 8.17-8.15 (dd, J1 = 8.5 Hz,
J2 = 1.0 Hz, 2H), 7.62-7.60 (d, J = 8.5 Hz, 2H), 5.69 (s, 1H), 5.62 (s, 1H),
4.48-4.47(d, J = 0.5 Hz, 2H). 13C-NMR (126 MHz, CDCl3): δ = 147.4, 144.0,
Synthesis of auxiliary building blocks:
Alcohol 9: The epoxide 8 [16] (869 mg, 4.85 mmol) was dissolved in neat
tert.-butylmercaptane (1.10 ml, 880 mg, 9.75 mmol) and a catalytical
amount of TBAF*3H2O (27 mg, 0.25 mmol) was added. The reaction
mixture was stirred at 50°C for 18 h and subsequently concentrated in
vacuo. The desired product (1.03 g, 3.81 mmol, 79%) was isolated as a
yellow oil after purification by flash-chromatography on silica-gel using
cyclohexane/ethylacetate (4/1) as a mobile phase. 1H-NMR (500 MHz,
CDCl3): δ = 8.14-8.11 (m, J1 = 9.0 Hz, , J2 = 2.5 Hz, J3 =2.0 Hz, 2H), 7.41-
7.39 (m, J1 = 9.0 Hz, , J2 = 2.5 Hz, J3 =2.0 Hz, 2H), 3.94-3.89 (m, 1H),
2.96- 2.93 (m, J1 = 13.5 Hz, , J2 = 4.5 Hz, 1H) 2.89-2.85 (m, J1 = 14.0 Hz, ,
J2 = 8.0 Hz, 1H), 2.76-2.72 (m, J1 = 13.0 Hz, , J2 = 4.5 Hz, 1H), 2.62 (s,
1H), 2.58-2.54 (m, J1 = 13.0 Hz, , J2 = 7.5 Hz, 1H), 1.29 (s, 9H). 13C-NMR
(126 MHz, CDCl3): δ = 146.8, 146.3, 130.4, 123.6, 70.6, 42.8, 42.5, 35.9,
31.1. HRMS (ESI): m/z = 270.1160 (C13H20NO3S (M+H)+, calc.: 270.1164);
C13H19NO3S: 269.35 g·mol−1
.
S-tBu-protected ketone 10: To a solution of the alcohol 9 (969 mg, 3.60
mmol) in a mixture of DCM/tert.butanol (22 ml, 9/1; v/v) was added Dess-
Martin periodinane (12.6 g, 4.43 mmol, 15 wt% solution in DCM). After 3.5
h the reaction was stopped by addition of a mixture of aqueous NaHCO3
(10 wt%, 10 ml) and aqueous NaHSO3 (saturated, 10 ml). The aqueous
phase was separated and extracted with ethylacetate (2x 20 ml). The
combined organic phases were dried over MgSO4 and subsequently
concentrated in vacuo. The desired product (558 mg, 2.09 mmol, 58%)
was isolated as a yellow solid after purification by flash-chromatography
on silica-gel using cyclohexane/ethylacetate (4/1) as a mobile phase. 1H-
NMR (500 MHz, CDCl3): δ = 8.16-8.14 (m, 2H), 7.39-7.37 (m, 2H), 4.06 (s,
2H), 3.36 (s, 2H), 1.30-1.29 (m, 9H). 13C-NMR (126 MHz, CDCl3): δ =
203.6, 147.1, 141.7, 130.7, 123.8, 46.4, 43.9, 39.5, 30.8. HRMS (ESI): m/z
= 266.0856 (C13H16NO3S (M-H)-, calc.: 266.0845); C13H17NO3S: 267.34
142.3, 127.0, 123.7, 120.3, 45.9. HRMS (ESI): m/z
= 220.0138
(C9H8ClNO2Na (M+Na)+, calc.: 220.0141); C9H8ClNO2: 197.62 g·mol−1
.
MAP-auxiliary glycine conjugate 19: To a solution of the allyl chloride
18 (435 mg, 2.20 mmol) in DCM (10 ml) was added subsequently glycine
tert-butyl ester hydrochloride (1.11 g, 6.60 mmol) and DIPEA (1.13 ml, 1.50
g, 11.7 mmol). After 16 h the reaction mixture was washed with (2 x 10 ml),
dried over MgSO4 and concentrated in vacuo. The desired glycine
intermediate 1 (555 mg, 1.90 mmol, 86%) was isolated as a yellow oil after
purification
by
flash-chromatography
on
silica-gel
using
g·mol−1
.
cyclohexane/ethylacetate (4/1) as a mobile phase. 1H-NMR (500 MHz,
CDCl3): δ = 8.19-8.16 (dt, J1 = 9.0 Hz, J2 = 2.5 Hz, 2H), 7.65-7.62 (dt, J1 =
9.0 Hz, J2 = 2.5 Hz, 2H), 5.57 (s, 1H), 5.44 (d, J = 1.0 Hz, 1H), 3.68 (d, J
= 1.0 Hz, 2H), 3.30 (s, 2H), 1.77 (s, 1H), 1.46 (s, 9H). 13C-NMR (126 MHz,
CDCl3): δ = 171.7, 147.3, 146.4, 144.4, 127.1, 123.8, 117.6, 81.5, 52.9,
50.8, 28.2. HRMS (ESI): m/z = 293.1496 (C15H21N2O4 (M+H)+, calc.:
293.1501); C15H20N2O4: 292.33 g·mol−1. The glycine intermediate1 (494
mg, 1.69 mmol) was dissolved in neat tert.-butylmercaptane (238 µL, 190
mg, 2.11 mmol) and a small amount of TBAF·3H2O (27 mg, 0.09 mmol)
was added. The reaction mixture was stirred at rt for 16 h and concentrated
in vacuo. The desired intermediate 2 (508 mg, 1.34 mmol, 79%) was
isolated as a yellow oil after purification by flash-chromatography on silica-
gel using cyclohexane/ethylacetate (4/1) as a mobile phase. 1H-NMR (500
MHz, CDCl3): δ = 8.18-8.16 (d, J = 3.5 Hz, 2H), 7.41-7.39 (d, J = 3.5 Hz,
2H), 3.27-3.19 (dd, , J1 = 17.0 Hz, J2 = 6.5 Hz, 2H), 3.10-3.04 (m , 2H)
2.98-2.94 (m, 2H), 2.91-2.87 (m, 2H), 2.76-2.72 (m, 2H), 1.51 (s, 1H), 1.42
(s, 9H), 1.25 (s, 9H). 13C-NMR (126 MHz, CDCl3): δ = 171.5, 150.4, 147.0,
Weinreb amide 14: To an ice-cold solution of N, O-dimethylhydroxylamine
hydrochloride (0.50 g, 5.13 mmol) in DCM (50 ml) was added DIPEA (1.33
g, 1.79 ml, 10.3 mmol) and dropwise bromoacetylbromide 12 (1.04 g, 446
µL, 5.13 mmol). The mixture was allowed to warm to room temperature
and stirred for 2.5 h. The organic phase was washed with sat. NaHSO4
solution (2 x 15 ml), dried over MgSO4 and concentrated in vacuo. The
residue was dissolved in DCM (25 ml). To this solution was added
triphenylmethyl mercaptan (1.70 g, 6.15 mmol) and DIPEA (0.66 g, 0.89
ml, 5.10 mmol). After 16 h the mixture was concentrated in vacuo. The
desired product (1.37 g, 3.62 mmol, 71%; C23H23NO2S; MW = 377.50
g·mol−1
) was isolated as white solid after purification by flash-
chromatography on silica-gel using cyclohexane/ethyl-acetate/EDMA
1
(2/1/0.01) as a mobile phase. H-NMR (300 MHz, CDCl3): δ = 7.50-7.46
(m, 6H), 7.35-7.21 (m, 9H), 3.48 (s, 3H), 3.13 (s, 3H), 3.10 (s, 2H).
This article is protected by copyright. All rights reserved.